Infection Complications after Lymphodepletion and Dosing of Chimeric Antigen Receptor T (CAR-T) Cell Therapy in Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia or B Cell Non-Hodgkin Lymphoma

SIMPLE SUMMARY: Chimeric antigen receptor T (CAR-T) cells have become clinical practice for the treatment of acute lymphoblastic leukemia and non-Hodgkin lymphoma. The aim of this retrospective study was to assess infection complications after lymphodepletion and CAR-T cell therapy. Infections were...

Descripción completa

Detalles Bibliográficos
Autores principales: Korell, Felix, Schubert, Maria-Luisa, Sauer, Tim, Schmitt, Anita, Derigs, Patrick, Weber, Tim Frederik, Schnitzler, Paul, Müller-Tidow, Carsten, Dreger, Peter, Schmitt, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8038233/
https://www.ncbi.nlm.nih.gov/pubmed/33918340
http://dx.doi.org/10.3390/cancers13071684

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8038233/
https://www.ncbi.nlm.nih.gov/pubmed/33918340
http://dx.doi.org/10.3390/cancers13071684

Ejemplares similares